Ahead of the Presidential elections in the United States of the America, President Donald Trump's administration is urging state authorities to speed up approval for COVID-19 vaccine distribution by November 1, which is just two days before the election polls.
WSJ report says, the federal government has asked State Governors to remove the roadblock to permits for distribution sites for use by the drug wholesaler's subsidiaries.
A letter by CDC Director Robert Redfield says, "CDC urgently requests your assistance in expediting applications for these distribution facilities , and if necessary, asks that you consider waiving requirements that would prevent these facilities from becoming fully operational by Nov 1 2020."
He also noted that the licensing waivers "will not compromise the safety and integrity of the products being distributed."
"Your assistance in helping expedite the issuance of necessary licenses and permits required for the distribution centers to become operational will be critical to the success of this public health effort to mitigate the threat presented by Covid-19," he said.
Prior to this, the United States FDA Commissioner Stephen Hahn told The Financial Times that the agency is prepared to bypass the full federal approval process in order to make COVID-19 vaccine as soon as possible.
He also made it clear that the move would not be due to pressure from the President Trump administration to fast-track the COVID-19 vaccine.
Nation's leading infectious disease expert Dr Anthony Fauci has previously said the United States could have results from one of the late stage trials by the month of November sooner.
"Thing are really right on the target," Fauci told earlier in the day. "I think you’ll know by the end of this year, November, December, that we do have a safe and effective vaccine."
According to the WSJ report, an FDA vaccine advisory committee will meet on October 22 to discuss authorization of Coronavirus vaccines.
On Monday, President Trump had announced that the vaccine for the COVID-19 being developed by AstraZeneca has reached phase three clinical trials in the country and is very close to being finalised for approval.
The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration to expedite the production of the Coronavirus vaccine.
According to the Johns Hopkins University COVID-19 dashboard, the United States is leading the world tally of COVID-19 with 6,111,485 cases and 185,674 deaths.